Canada India Health Care Summit May 19-20 2015 BlueOcean NutraSciences (“BlueOcean”) is listed on the TSX Venture Exchange (TSXV:BOC) This presentation contains certain forward-looking statements. Forward-looking statements are statements that are not historical facts, and include but are not limited to, estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to the effectiveness of BlueOcean’s business model, future operations, products and services; the impact of regulatory initiatives on BlueOcean’s operations, the size of and opportunities related to the markets for their products; general industry and macroeconomic growth rates, expectations related to possible joint and/or strategic ventures and statements regarding future performance. The forward-looking statements contained in this presentation are made as of the date hereof. Unless required by law, BlueOcean’s does not undertake any obligation to update publically or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise The Common Shares of the Corporation have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This presentation shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of any securities of the Corporation in any jurisdiction in which such offer, solicitation or sale would be unlawful. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this presentation. All figures are in United States Dollars (US$) unless otherwise stated. BlueOcean’s Management Bios Gavin Bogle, JD, MBA, MS – Chief Executive Officer Mr. Bogle has been an intellectual property, regulatory, and licensing attorney for over 20 years in mostly the North American biotechnology, pharmaceutical and supplement industries. He has extensive cross-border transactional experience including intellectual property aspects of corporate transactions such as licensing, contracts and collaborations, acquisitions, financings, divestitures and managing intellectual property holdings. Benefits of Omega 3 In a special edition of Military Medicine: “Nutritional Armor: Omega-3 for the Warfighter”. … The Panel concluded that there was “sufficient evidence to support increasing omega-3 intake to receive cardiovascular, immunological, and surgical benefits.” … ... Evidence for reduction of depressive symptoms and suicide prevention was felt to be strong … Adverse side effects were deemed negligible. “The Panel concluded that based on studies analyzing omega-3 and omega-6 FA balance, it would be unethical to not attempt elevating the omega-3 status among U.S. military personnel.” See: “US Military Evalulating Benefits of Omega-3 Supplementation By Michael McBurney” http://www.dsm.com/campaigns/talkingnutrition/en_US/talkingnutrition-dsmcom/2014/11/us_military_evalulate_omega3.html” BlueOcean’s AstaShrimp Oils AstaShrimp oils are dark red due to high natural Astaxanthin content. AstaShrimp oils are viscous liquids due to high phospholipids content. These oils can be blended with other fish oils to reduce viscosity if desired. BlueOcean’s AlgaOmega Oil BlueOcean has a proprietary patented CO2 gas infusion technology to make high yielding non-GMO high omega-3 EPA/DHA algal oils for vegetarian and adult customers. Commercial Strategy • Forming a JV or an out-license with a commercial algae omega-3/nutraceutical company • BlueOcean continues to explore building a wholly owned algae plant for its own AlgaOmega oils BlueOcean’s Nutra Tablets BlueOcean converts shrimp, krill, algae and other fish oils into slow release Omega-3 oil tablets • First Omega-3 oil tablets on the market • 500 mg tablet sizes that can vary in size, shape and color • Tablet oils can be shrimp, krill, omega-3 and astaxanthin algae, and fish oils • Custom formulations of EPA, DHA, Astaxanthin and Phospholipids • Extended release and high bioavailability from pharmaceutical applied technology • No fishy smell, taste or burping • NO SOFT GELS = NO BEEF PRODUCTS Fish oil tablets with 500 mg of oil containing 36% EPA & 24% DHA BlueOcean’s Strong Indian Partnership INDFRAG LIMITED • In 1989 Indfrag was started to extract the essence of natural flowers to be used as ingredients in fine perfumery in collaboration with Bertrand Freres located in the south of France • In the early 1990s, Indfrag diversified and expanded into botanical extracts used in Healthcare such as Garcinia • Indfrag has grown to be one of the largest extraction facilities in India with a total of nine extraction facilities across Asian countries • Today Indfrag can load 400 metric tonnes of raw botanical every month. • GMP regulation certified by NSF. BlueOcean’s Strong Indian Partnership INDFRAG BlueOcean’s Indian Omega-3 Market Opportunity India’s Omega-3 Market • $1.5B Dietary Supplements Market • High growth market – 16% CAGR • Only 5% of the Indian market is Omega-3’s Challenges with Indian Omega-3 use • >30% of population is strict vegetarian • >75% of India’s population is Hindu and therefore DOES NOT EAT BEEF, but 60% still eat chicken and seafood • Omega-3 fish oil gel caps are BEEF GELATIN • Gelcaps are 4 times more expensive vs tablets BlueOcean’s Solutions For Indian Omega-3 use • For India’s 600M non-vegetarian but non beef consumers: Omega-3 Fish and Shrimp Oil Tablets • For the 300M vegetarians: Omega-3 Algae Tablets Thank You For more information please contact us: [email protected] Tel: 416-970-3266 www.blueoceannutra.ca
© Copyright 2024